ABLG yields 2.71% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, ABLG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ABLG + JNJ for your $10,000?
ABLG aims to outperform a broad global ex-US equity index, the MSCI All Country World Index ex USA, through an active investment process. A quant model is used to rank stocks based on proprietary measures of free cash flow. Firms that are highly leveraged, incur debt to buy back shares, or do not satisfy ESG criteria are screened out. Approximately 150 of the highest-ranked stocks are selected and then weighted on a modified market-cap basis that factors in free cash flow and log transformation. TTAI applies tight portfolio manager discretion beyond its rules-based approach. Note: Prior to May 29, 2020, the funds methodology emphasized share buyback trends before implementing more changes on Mar. 1, 2021. On Nov. 18, 2020, the funds name was changed from TrimTabs All Cap International Free-Cash-Flow ETF to TrimTabs International Free Cash Flow Quality ETF. It held the name until Nov. 29, 2021. Prior to Nov 13, 2024, the fund name was FCF International Quality ETF and traded under the ticker TTAI.
Full ABLG Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.